Alnylam Pharmaceuticals, Inc. (ALNY): Price and Financial Metrics


Alnylam Pharmaceuticals, Inc. (ALNY)

Today's Latest Price: $117.66 USD

5.17 (4.60%)

Updated Feb 28 12:00am

Add ALNY to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 338 in Biotech

See all "A" rated Strong Buy stocks

ALNY Stock Summary

  • ALNY's price/sales ratio is 77.86; that's higher than the P/S ratio of 97.3% of US stocks.
  • With a year-over-year growth in debt of 915.4%, Alnylam Pharmaceuticals Inc's debt growth rate surpasses 97.22% of about US stocks.
  • Revenue growth over the past 12 months for Alnylam Pharmaceuticals Inc comes in at 84.21%, a number that bests 93.33% of the US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Alnylam Pharmaceuticals Inc are GNTX, HRTX, FOLD, MXIM, and CLVS.
  • ALNY's SEC filings can be seen here. And to visit Alnylam Pharmaceuticals Inc's official web site, go to www.alnylam.com.
ALNY Daily Price Range
ALNY 52-Week Price Range

ALNY Stock Price Chart More Charts


ALNY Price/Volume Stats

Current price $117.66 52-week high $134.51
Prev. close $112.49 52-week low $65.81
Day low $106.28 Volume 1,106,900
Day high $118.56 Avg. volume 692,930
50-day MA $119.82 Dividend yield N/A
200-day MA $92.52 Market Cap 13.25B

Alnylam Pharmaceuticals, Inc. (ALNY) Company Bio


Alnylam Pharmaceuticals is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company was founded in 2002 and is based in Cambridge, Massachusetts.


ALNY Latest News Stream


Event/Time News Detail
Loading, please wait...

ALNY Latest Social Stream


Loading social stream, please wait...

View Full ALNY Social Stream

ALNY Price Returns

1-mo 1.91%
3-mo 0.44%
6-mo 45.82%
1-year 37.82%
3-year 129.36%
5-year 11.63%
YTD 2.16%
2019 57.96%
2018 -42.61%
2017 239.34%
2016 -60.23%
2015 -2.95%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6743 seconds.